Become a Member
  • Track your favourite stocks
  • Create & monitor portfolios
  • Daily portfolio value
Sign Up
Quickpicks
Add shares to your
quickpicks to
display them here!

Int.biotech. (IBT) Share Price

Price 866.00p on 14-11-2025 at 08:57:09
Change -6.00p -0.69%
Buy 872.00p
Sell 860.00p
Last Trade: Sell 5,658.00 at 860.114p
Day's Volume: 13,363
Last Close: 872.00p
Open: 866.00p
ISIN: GB0004559349
Day's Range 866.00p - 866.00p
52wk Range: 480.00p - 890.00p
Market Capitalisation: £277.37m
VWAP: 862.93067p
Shares in Issue: 32.03m

Int.biotech. (IBT) Latest Trades

Buy/Sell Volume Trade Prc Trade Type Trade Time
Sell* 5,658 860.114p Ordinary
08:57:08 - 14-Nov-25
Sell* 1,740 866.00p Automatic Execution
08:55:34 - 14-Nov-25
Sell* 360 866.00p Automatic Execution
08:55:34 - 14-Nov-25
Sell* 681 868.084p Ordinary
08:52:10 - 14-Nov-25
Unknown* 0 874.00p SI Trade
08:51:55 - 14-Nov-25
Unknown* 0 856.00p SI Trade
08:42:43 - 14-Nov-25
Buy* 5 867.97p Ordinary
08:42:22 - 14-Nov-25
Sell* 1,177 860.698p Ordinary
08:38:43 - 14-Nov-25
Buy* 572 868.06p Ordinary
08:34:26 - 14-Nov-25
Buy* 1 874.00p SI Trade
08:24:46 - 14-Nov-25
See more Int.biotech. trades

Int.biotech. (IBT) Share Price History

Time period:
to
Date Open High Low Close Volume
14th Nov 2025 (Fri) 866.00 866.00 866.00 872.00 13,363
13th Nov 2025 (Thu) 890.00 890.00 872.00 872.00 59,318
12th Nov 2025 (Wed) 866.00 890.00 866.00 882.00 124,902
11th Nov 2025 (Tue) 860.00 860.00 844.00 858.00 103,174
10th Nov 2025 (Mon) 826.00 850.00 826.00 850.00 127,839
7th Nov 2025 (Fri) 844.00 846.00 812.00 812.00 239,847
6th Nov 2025 (Thu) 840.00 840.00 832.00 840.00 439,766
5th Nov 2025 (Wed) 840.00 840.00 824.00 826.00 106,750
4th Nov 2025 (Tue) 840.00 842.00 834.00 834.00 308,834
3rd Nov 2025 (Mon) 868.00 878.00 828.00 828.00 320,733
31st Oct 2025 (Fri) 874.00 876.00 860.00 860.00 56,655
30th Oct 2025 (Thu) 860.00 872.00 856.00 866.00 116,593
29th Oct 2025 (Wed) 860.00 864.00 856.00 860.00 150,055
28th Oct 2025 (Tue) 852.00 854.00 848.00 850.00 84,256
27th Oct 2025 (Mon) 836.00 858.00 836.00 848.00 157,359
24th Oct 2025 (Fri) 830.00 830.00 824.00 826.00 91,047
23rd Oct 2025 (Thu) 818.00 824.00 816.00 816.00 91,950
22nd Oct 2025 (Wed) 828.00 830.00 818.00 820.00 145,658
21st Oct 2025 (Tue) 830.00 834.00 822.00 834.00 132,664
20th Oct 2025 (Mon) 814.00 828.00 814.00 826.00 71,750
17th Oct 2025 (Fri) 816.00 816.00 800.00 812.00 273,220
16th Oct 2025 (Thu) 824.00 838.00 822.00 828.00 112,042
15th Oct 2025 (Wed) 808.00 824.00 806.00 824.00 298,182
14th Oct 2025 (Tue) 818.00 820.00 802.00 802.00 206,286
See more Int.biotech. price history

Int.biotech. (IBT) Regulatory News

Date Source Headline
13th Nov 2025 11:43 am RNS Net Asset Value(s)
12th Nov 2025 11:29 am RNS Net Asset Value(s)
11th Nov 2025 5:41 pm RNS Transaction in Own Shares
11th Nov 2025 11:51 am RNS Net Asset Value(s)
10th Nov 2025 6:03 pm RNS Transaction in Own Shares
10th Nov 2025 12:00 pm RNS Net Asset Value(s)
7th Nov 2025 5:15 pm RNS Transaction in Own Shares
7th Nov 2025 11:42 am RNS Net Asset Value(s)
7th Nov 2025 7:00 am RNS Annual Financial Report on NSM
6th Nov 2025 5:23 pm RNS Transaction in Own Shares
See more Int.biotech. regulatory news

Int.biotech. (IBT) Share News

International Biotechnology beats benchmark with 0.7% NAV gain

6th Nov 2025 19:17

(Alliance News) - International Biotechnology Trust PLC on Thursday said its portfolio continued to outperform the sector benchmark as the company reported full-year results. Read More

IN BRIEF: International Biotechnology Trust notes Novo to buy Akero

9th Oct 2025 15:40

International Biotechnology Trust PLC - investor in biotech and life science companies - Notes portfolio firm Akero Therapeutics Inc as agreed to be taken over by Novo Nordisk AS in a deal worth up to EUR5.2 billion. Novo Nordisk will pay an initial USD54 per share, with a contingent portion of the deal worth USD6 per share. The Bagsvaerd, Denmark-based pharmaceuticals company will pay an initial EUR4.7 billion to buy the firm, and a potential additional payment of EUR500 million, hinging on US regulatory approval for key Akero treatment Efruxifermin. The deal adds Akero's Efruxifermin to Novo Nordisk's portfolio. The asset is aimed at treating metabolic dysfunction-associated steatohepatitis, a disease caused by fat buildup in the liver. Read More

International Biotechnology to raise unquoted exposure with Schroders

2nd Oct 2025 13:31

(Alliance News) - International Biotechnology Trust PLC on Thursday said it has partnered with Schroders Capital to access more investees in the earlier stages of development. Read More

UK dividends calendar - next 7 days

15th Aug 2025 16:46

Read More

UK dividends calendar - next 7 days

17th Jul 2025 14:22

Read More

See more Int.biotech. news
FTSE 100 Latest
Value9,708.00
Change-99.68

Login to your account

Forgot Password?

Not Registered